New insights into the mechanisms of multidrug resistance in cancers

N Montazami; M Aghapour; S Farajnia; B Baradaran

Issue

Vol. 61 No. 7: Issue 7

Issue Published : November 30, 2015

The undersigned hereby assign all rights, included but not limited to copyright, for this manuscript to CMB Association upon its submission for consideration to publication on Cellular and Molecular Biology. The rights assigned include, but are not limited to, the sole and exclusive rights to license, sell, subsequently assign, derive, distribute, display and reproduce this manuscript, in whole or in part, in any format, electronic or otherwise, including those in existence at the time this agreement was signed. The authors hereby warrant that they have not granted or assigned, and shall not grant or assign, the aforementioned rights to any other person, firm, organization, or other entity. All rights are automatically restored to authors if this manuscript is not accepted for publication.

New insights into the mechanisms of multidrug resistance in cancers

N Montazami

Tabriz University of Medical Sciences Immunology Research Center Tabriz Iran

M Aghapour

University of Tabriz Department of Pathobiology, Faculty of Veterinary Medicine Tabriz Iran

S Farajnia

Tabriz University of Medical Sciences Immunology Research Center Tabriz Iran

B Baradaran

Tabriz University of Medical Sciences Immunology Research Center Tabriz Iran

Corresponding Author(s) : N Montazami

Cellular and Molecular Biology, Vol. 61 No. 7: Issue 7
Article Published : November 25, 2015

Abstract

Drug resistance is one of the major obstacles in the treatment of various cancers. Since chemotherapy serves as a most beneficial method for the repression of tumor progression and due to its desirable cell death potency in tumors which reducing metastasis, failure of such a pivotal treatment lead to tumor recurrence and consequent mortality. Multidrug resistance, the principal mechanism by which many cancers develop resistance to chemotherapy drugs, is a major factor in the failure of many forms of chemotherapy. MDR1 overexpression is one form of the multidrug resistance (MDR) phenotype, which can be acquired by patients initially responsive to chemotherapy. In this review, we briefly look inside the recent mechanisms of chemotherapeutic resistance, the MDR1 gene expression in tumors and some novel inhibition-based approaches.

Keywords

Chemotherapy Drug resistance Cancer.

Montazami, N., Aghapour, M., Farajnia, S., & Baradaran, B. (2015). New insights into the mechanisms of multidrug resistance in cancers. Cellular and Molecular Biology, 61(7), 70–80. Retrieved from https://mail.cellmolbiol.org/index.php/CMB/article/view/741